These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7207623)

  • 21. [Myasthenia gravis (2). Antibodies against acetylcholinergic receptros in myasthenia gravis].
    Bergström K; Lefvert AK
    Lakartidningen; 1978 Oct; 75(41):3665-7. PubMed ID: 692232
    [No Abstract]   [Full Text] [Related]  

  • 22. Myasthenia gravis and the anti-idiotype theory of autoimmunity.
    Bradley RJ
    Lancet; 1984 Feb; 1(8373):396. PubMed ID: 6141456
    [No Abstract]   [Full Text] [Related]  

  • 23. [Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis].
    Heilbronn E
    Lakartidningen; 1978 Oct; 75(41):3663-4, 3669. PubMed ID: 692231
    [No Abstract]   [Full Text] [Related]  

  • 24. Acetylcholine receptor: molecular dissection and monoclonal antibodies in the study of experimental myasthenia.
    Fuchs S; Bartfeld D; Mochly-Rosen D; Souroujon M; Feingold C
    Ann N Y Acad Sci; 1981; 377():110-24. PubMed ID: 6176165
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibodies to muscarinic acetylcholine receptors in myasthenia gravis.
    Michaelson DM; Korczyn AD; Sokolovsky M
    Biochem Biophys Res Commun; 1982 Jan; 104(1):52-7. PubMed ID: 7073682
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of experimental myasthenia with autologous idiotypes linked to muramyl dipeptide.
    Valderrama R; Eggers AE; Moomjy M; Kao PN; Michl J
    Clin Exp Immunol; 1988 Jul; 73(1):123-7. PubMed ID: 3168327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients.
    Dwyer DS; Bradley RJ; Urquhart CK; Kearney JF
    Nature; 1983 Feb 17-23; 301(5901):611-4. PubMed ID: 6402708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiotypic network connectivity and a possible cause of myasthenia gravis.
    Dwyer DS; Vakil M; Kearney JF
    J Exp Med; 1986 Oct; 164(4):1310-8. PubMed ID: 2428915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiacetylcholine receptor antibodies and myasthenia gravis.
    Richter PL
    JAMA; 1982 Jun; 247(22):3082-3. PubMed ID: 7077800
    [No Abstract]   [Full Text] [Related]  

  • 31. Characterization of anti-acetylcholine receptor antibody activity in patients with anti-mitochondrial antibodies.
    Sundewall AC; Lefvert AK; Norberg R
    Clin Immunol Immunopathol; 1987 Nov; 45(2):184-95. PubMed ID: 3665199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children.
    Lefvert AK; Osterman PO
    Neurology; 1983 Feb; 33(2):133-8. PubMed ID: 6681654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylcholine receptor antibodies in penicillamine-induced myasthenia gravis.
    Bocanegra TS; Espinoza LR; Vasey FB; Germain BF; Jaffe IA; Penn AS
    JAMA; 1981 Oct 23-30; 246(17):1901. PubMed ID: 7288965
    [No Abstract]   [Full Text] [Related]  

  • 34. Autoantibodies to acetylcholine receptors in myasthenia gravis.
    N Engl J Med; 1983 Feb; 308(7):402-3. PubMed ID: 6823248
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of autoimmune reactivity against acetylcholine receptor with idiotype-specific immunotoxins.
    Krolick KA
    Methods Enzymol; 1989; 178():448-55. PubMed ID: 2601628
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipoprotein-like receptor 4 antibodies in myasthenia gravis: pathogenic or protective.
    Richman DP
    Eur J Neurol; 2016 Nov; 23(11):1593-1594. PubMed ID: 27753233
    [No Abstract]   [Full Text] [Related]  

  • 37. 'Seronegative' myasthenia gravis is no longer seronegative.
    Lindstrom J
    Brain; 2008 Jul; 131(Pt 7):1684-5. PubMed ID: 18558616
    [No Abstract]   [Full Text] [Related]  

  • 38. Receptors in immunology.
    Gmelig Meyling FH
    Neth J Med; 1985; 28(2):63-8. PubMed ID: 3919325
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum Acetylcholine Receptor Antibodies Before the Clinical Onset of Myasthenia Gravis.
    Strijbos E; Verschuuren JJGM; Kuks JBM
    J Neuromuscul Dis; 2018; 5(2):261-264. PubMed ID: 29865092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic and genetic factors in autoimmune diseases.
    Shoenfeld Y; Schwartz RS
    N Engl J Med; 1984 Oct; 311(16):1019-29. PubMed ID: 6384779
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.